Skip to content
LINK BIOLOGICS
Our Pipeline
Our Team
Our News
LINK BIOLOGICS
Our Pipeline
Our Team
Our News
Our news
Link Biologics completes IND-enabling preclinical programme for LB001, a first-in-class novel therapy for dry eye disease
5 November 2026
View Release
Link Biologics strengthens IP position for Link_TSG6 with US patent Notice of Allowance and University of Manchester IP assignment
6 May 2026
View Release
Link Biologics strengthens Board with drug discovery expert Dr Niall Martin to advance its TSG-6-based therapeutic pipeline
24 February 2026
View Release
Promising novel treatment for Dry Eye Disease revealed by new research
2 September 2025
View Release
Promising novel treatment for Osteoarthritis revealed by new research
5 June 2025
View Release
Link Biologics founder Tony Day elected to Academy of Medical Sciences
22 May 2025
View Release